Antiretroviral Drug Market, Global Outlook and Forecast 2023-2028

Report ID: 1637027 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Antiretroviral Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Antiretroviral Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Antiretroviral Drug Overall Market Size
    2.1 Global Antiretroviral Drug Market Size: 2021 VS 2028
    2.2 Global Antiretroviral Drug Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Antiretroviral Drug Players in Global Market
    3.2 Top Global Antiretroviral Drug Companies Ranked by Revenue
    3.3 Global Antiretroviral Drug Revenue by Companies
    3.4 Top 3 and Top 5 Antiretroviral Drug Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Antiretroviral Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Antiretroviral Drug Players in Global Market
        3.6.1 List of Global Tier 1 Antiretroviral Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 Antiretroviral Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Antiretroviral Drug Market Size Markets, 2021 & 2028
        4.1.2 Multi-Class Drugs Combination
        4.1.3 NRTI
        4.1.4 NNRTI
        4.1.5 Protease Inhibitors
        4.1.6 Other
    4.2 By Type - Global Antiretroviral Drug Revenue & Forecasts
        4.2.1 By Type - Global Antiretroviral Drug Revenue, 2017-2022
        4.2.2 By Type - Global Antiretroviral Drug Revenue, 2023-2028
        4.2.3 By Type - Global Antiretroviral Drug Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Antiretroviral Drug Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Pharmaceutical Companies
        5.1.4 Other
    5.2 By Application - Global Antiretroviral Drug Revenue & Forecasts
        5.2.1 By Application - Global Antiretroviral Drug Revenue, 2017-2022
        5.2.2 By Application - Global Antiretroviral Drug Revenue, 2023-2028
        5.2.3 By Application - Global Antiretroviral Drug Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Antiretroviral Drug Market Size, 2021 & 2028
    6.2 By Region - Global Antiretroviral Drug Revenue & Forecasts
        6.2.1 By Region - Global Antiretroviral Drug Revenue, 2017-2022
        6.2.2 By Region - Global Antiretroviral Drug Revenue, 2023-2028
        6.2.3 By Region - Global Antiretroviral Drug Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Antiretroviral Drug Revenue, 2017-2028
        6.3.2 US Antiretroviral Drug Market Size, 2017-2028
        6.3.3 Canada Antiretroviral Drug Market Size, 2017-2028
        6.3.4 Mexico Antiretroviral Drug Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Antiretroviral Drug Revenue, 2017-2028
        6.4.2 Germany Antiretroviral Drug Market Size, 2017-2028
        6.4.3 France Antiretroviral Drug Market Size, 2017-2028
        6.4.4 U.K. Antiretroviral Drug Market Size, 2017-2028
        6.4.5 Italy Antiretroviral Drug Market Size, 2017-2028
        6.4.6 Russia Antiretroviral Drug Market Size, 2017-2028
        6.4.7 Nordic Countries Antiretroviral Drug Market Size, 2017-2028
        6.4.8 Benelux Antiretroviral Drug Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Antiretroviral Drug Revenue, 2017-2028
        6.5.2 China Antiretroviral Drug Market Size, 2017-2028
        6.5.3 Japan Antiretroviral Drug Market Size, 2017-2028
        6.5.4 South Korea Antiretroviral Drug Market Size, 2017-2028
        6.5.5 Southeast Asia Antiretroviral Drug Market Size, 2017-2028
        6.5.6 India Antiretroviral Drug Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Antiretroviral Drug Revenue, 2017-2028
        6.6.2 Brazil Antiretroviral Drug Market Size, 2017-2028
        6.6.3 Argentina Antiretroviral Drug Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Antiretroviral Drug Revenue, 2017-2028
        6.7.2 Turkey Antiretroviral Drug Market Size, 2017-2028
        6.7.3 Israel Antiretroviral Drug Market Size, 2017-2028
        6.7.4 Saudi Arabia Antiretroviral Drug Market Size, 2017-2028
        6.7.5 UAE Antiretroviral Drug Market Size, 2017-2028
7 Players Profiles
    7.1 Gilead Sciences
        7.1.1 Gilead Sciences Corporate Summary
        7.1.2 Gilead Sciences Business Overview
        7.1.3 Gilead Sciences Antiretroviral Drug Major Product Offerings
        7.1.4 Gilead Sciences Antiretroviral Drug Revenue in Global Market (2017-2022)
        7.1.5 Gilead Sciences Key News
    7.2 ViiV Healthcare
        7.2.1 ViiV Healthcare Corporate Summary
        7.2.2 ViiV Healthcare Business Overview
        7.2.3 ViiV Healthcare Antiretroviral Drug Major Product Offerings
        7.2.4 ViiV Healthcare Antiretroviral Drug Revenue in Global Market (2017-2022)
        7.2.5 ViiV Healthcare Key News
    7.3 Bristol-Myer Squibb
        7.3.1 Bristol-Myer Squibb Corporate Summary
        7.3.2 Bristol-Myer Squibb Business Overview
        7.3.3 Bristol-Myer Squibb Antiretroviral Drug Major Product Offerings
        7.3.4 Bristol-Myer Squibb Antiretroviral Drug Revenue in Global Market (2017-2022)
        7.3.5 Bristol-Myer Squibb Key News
    7.4 AbbVie
        7.4.1 AbbVie Corporate Summary
        7.4.2 AbbVie Business Overview
        7.4.3 AbbVie Antiretroviral Drug Major Product Offerings
        7.4.4 AbbVie Antiretroviral Drug Revenue in Global Market (2017-2022)
        7.4.5 AbbVie Key News
    7.5 Boehringer-Ingelheim
        7.5.1 Boehringer-Ingelheim Corporate Summary
        7.5.2 Boehringer-Ingelheim Business Overview
        7.5.3 Boehringer-Ingelheim Antiretroviral Drug Major Product Offerings
        7.5.4 Boehringer-Ingelheim Antiretroviral Drug Revenue in Global Market (2017-2022)
        7.5.5 Boehringer-Ingelheim Key News
    7.6 Johnson and Johnson
        7.6.1 Johnson and Johnson Corporate Summary
        7.6.2 Johnson and Johnson Business Overview
        7.6.3 Johnson and Johnson Antiretroviral Drug Major Product Offerings
        7.6.4 Johnson and Johnson Antiretroviral Drug Revenue in Global Market (2017-2022)
        7.6.5 Johnson and Johnson Key News
    7.7 Merck
        7.7.1 Merck Corporate Summary
        7.7.2 Merck Business Overview
        7.7.3 Merck Antiretroviral Drug Major Product Offerings
        7.7.4 Merck Antiretroviral Drug Revenue in Global Market (2017-2022)
        7.7.5 Merck Key News
    7.8 CIPLA
        7.8.1 CIPLA Corporate Summary
        7.8.2 CIPLA Business Overview
        7.8.3 CIPLA Antiretroviral Drug Major Product Offerings
        7.8.4 CIPLA Antiretroviral Drug Revenue in Global Market (2017-2022)
        7.8.5 CIPLA Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Antiretroviral Drug Market Opportunities & Trends in Global Market
    Table 2. Antiretroviral Drug Market Drivers in Global Market
    Table 3. Antiretroviral Drug Market Restraints in Global Market
    Table 4. Key Players of Antiretroviral Drug in Global Market
    Table 5. Top Antiretroviral Drug Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Antiretroviral Drug Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Antiretroviral Drug Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Antiretroviral Drug Product Type
    Table 9. List of Global Tier 1 Antiretroviral Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Antiretroviral Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Antiretroviral Drug Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Antiretroviral Drug Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Antiretroviral Drug Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Antiretroviral Drug Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Antiretroviral Drug Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Antiretroviral Drug Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Antiretroviral Drug Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Antiretroviral Drug Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Antiretroviral Drug Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Antiretroviral Drug Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Antiretroviral Drug Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Antiretroviral Drug Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Antiretroviral Drug Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Antiretroviral Drug Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Antiretroviral Drug Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Antiretroviral Drug Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Antiretroviral Drug Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Antiretroviral Drug Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Antiretroviral Drug Revenue, (US$, Mn), 2023-2028
    Table 30. Gilead Sciences Corporate Summary
    Table 31. Gilead Sciences Antiretroviral Drug Product Offerings
    Table 32. Gilead Sciences Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
    Table 33. ViiV Healthcare Corporate Summary
    Table 34. ViiV Healthcare Antiretroviral Drug Product Offerings
    Table 35. ViiV Healthcare Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
    Table 36. Bristol-Myer Squibb Corporate Summary
    Table 37. Bristol-Myer Squibb Antiretroviral Drug Product Offerings
    Table 38. Bristol-Myer Squibb Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
    Table 39. AbbVie Corporate Summary
    Table 40. AbbVie Antiretroviral Drug Product Offerings
    Table 41. AbbVie Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
    Table 42. Boehringer-Ingelheim Corporate Summary
    Table 43. Boehringer-Ingelheim Antiretroviral Drug Product Offerings
    Table 44. Boehringer-Ingelheim Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
    Table 45. Johnson and Johnson Corporate Summary
    Table 46. Johnson and Johnson Antiretroviral Drug Product Offerings
    Table 47. Johnson and Johnson Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
    Table 48. Merck Corporate Summary
    Table 49. Merck Antiretroviral Drug Product Offerings
    Table 50. Merck Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
    Table 51. CIPLA Corporate Summary
    Table 52. CIPLA Antiretroviral Drug Product Offerings
    Table 53. CIPLA Antiretroviral Drug Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Antiretroviral Drug Segment by Type in 2021
    Figure 2. Antiretroviral Drug Segment by Application in 2021
    Figure 3. Global Antiretroviral Drug Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Antiretroviral Drug Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Antiretroviral Drug Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Antiretroviral Drug Revenue in 2021
    Figure 8. By Type - Global Antiretroviral Drug Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Antiretroviral Drug Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Antiretroviral Drug Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Antiretroviral Drug Revenue Market Share, 2017-2028
    Figure 12. US Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Antiretroviral Drug Revenue Market Share, 2017-2028
    Figure 16. Germany Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 17. France Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Antiretroviral Drug Revenue Market Share, 2017-2028
    Figure 24. China Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 28. India Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Antiretroviral Drug Revenue Market Share, 2017-2028
    Figure 30. Brazil Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Antiretroviral Drug Revenue Market Share, 2017-2028
    Figure 33. Turkey Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Antiretroviral Drug Revenue, (US$, Mn), 2017-2028
    Figure 37. Gilead Sciences Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. ViiV Healthcare Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Bristol-Myer Squibb Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. AbbVie Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Boehringer-Ingelheim Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Johnson and Johnson Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Merck Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. CIPLA Antiretroviral Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
60
Frequently Asked Questions
Antiretroviral Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antiretroviral Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antiretroviral Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports